Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by PTGER3 is a member of the G-protein coupled receptor family.
Showing 10 out of 23 products:
Study reports that EP3 expression is elevated in TSC2- deficient patient-derived cells compared with TSC2-addback cells, and that EP3 antagonist selectively suppresses the proliferation of TSC2-deficient cells. The elevated expression of EP3 is mediated by Rheb in an mTORC1-independent fashion.
Study showed the EP3 expression is correlated to the FIGO classification and, demonstrates that an increased EP3 expression correlates with a negative outcome of overall survival of cervical carcinoma patients. In addition, different expression of EP3 was found in correlation to the histological subtype. Patients with adenocarcinoma and high expression of EP3 had a worse outcome survival.
EP2 and EP3 receptors are involved in tolerance induction through IL-10 (show IL10 ELISA Kits) production by tol-DCs.
findings show that prostaglandin E2 EP3 receptor contributes to thrombin (show F2 ELISA Kits)-induced brain damage via Rho-Rho kinase (show ROCK1 ELISA Kits)-mediated cytotoxicity and proinflammatory responses.
S211L within EP3 is the key residue to distinguish PGE1 and PGE2 binding to mediate diverse biological functions at the initial recognition step
The present study identified the functions of EP3 and the mechanisms by which PGE2 regulates beta-catenin (show CTNNB1 ELISA Kits) expression and promoted cholangiocarcinoma cell growth and invasion
Our results show that oxLDL suppresses EP3 expression by activation of PPAR-g (show ARF6 ELISA Kits) and subsequent inhibition of NF-kappaB (show NFKB1 ELISA Kits) in macrophages.
results demonstrate that risk of unsuccessful periodontal treatment is associated with tag SNPs in specific genes that regulate the inflammatory response, one of which is also associated with sPTB.
Failure of cervical ripening, after local application of prostaglandins for labor induction, may be caused by the increased expression of EP3 and concomitant decrease in EP4 expression.
Human prostate cancer is associated with EP4 and EP2 overexpression and reduced EP3 expression.
For the mutant receptors, the second extracellular loop (ECII) plays a critical role in linking the agonist bound receptor conformation to the G protein nucleotide bound state.
GMSC administration promoted the expression of EP3.
EP3 receptor and its alpha and gamma isoforms are involved in both adipogenesis and lipolysis and influence food intake, serum lipid levels, and insulin (show INS ELISA Kits) sensitivity.
PGE2 reduces contractility of the in vivo heart, the isolated working heart, and single adult ventricular myocytes via its EP3 receptor.
Activation of the EP3 receptor facilitates sprouting angiogenesis through protein kinase A/beta-catenin (show CTNNB1 ELISA Kits)/notch (show NOTCH1 ELISA Kits) signaling.
Data show that prostaglandin E2 receptor EP3 subtype (EP3) was expressed in the interstitial cells of Cajal (ICCs) of the bladder and activated hyperpolarization-activated cyclic nucleotide-gated (HCN) channels.
Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 (show CYSLTR1 ELISA Kits) and E-prostanoid receptor 3
Data (including data from studies in knockout mice) suggest that Ptger3 is involved in regulation of adiposity, lipid metabolism, and insulin (show INS ELISA Kits) resistance; Ptger3 knockout mice gain more weight on high-fat diet than normal mice.
EP3 activation facilitates hypoxia-induced vascular remodeling and pulmonary hypertension in mice.
EP3 and TLR3 (show TLR3 ELISA Kits) in conjunctival epithelium play a critical role in regulating ocular surface inflammation.
PGE2 triggers mast cell activation via an EP3-Gi/o-Ca(2+) influx/PI3K pathway. This mechanism underlies PGE2-induced vascular permeability and consequent edema formation.
vasoconstriction is mediated by phosphatidyl-inositol pathway via activation of EP1- and EP3-receptors located on the smooth muscle cells
The protein encoded by this gene is a member of the G-protein coupled receptor family. This protein is one of four receptors identified for prostaglandin E2 (PGE2). This receptor may have many biological functions, which involve digestion, nervous system, kidney reabsorption, and uterine contraction activities. Studies of the mouse counterpart suggest that this receptor may also mediate adrenocorticotropic hormone response as well as fever generation in response to exogenous and endogenous stimuli. Multiple transcript variants encoding different isoforms have been found for this gene.
prostaglandin E2 receptor EP3 subtype
, prostaglandin E receptor 3, subtype EP3
, prostaglandin E receptor 3 (subtype EP3)
, PGE receptor, EP3 subtype
, PGE2 receptor EP3 subtype
, prostaglandin E receotor EP3 subtype 3 isoform
, prostaglandin receptor (PGE-2)
, prostanoid EP3 receptor
, PGE receptor EP3 subtype
, prostaglandin EP3 receptor subtype
, prostaglandin E receptor EP3 subtype
, prostaglandin E2 receptor EP3B subtype
, Prostaglandin E2 receptor EP3 subtype